The FDA has granted Becton Dickinson 510(k) clearance for its molecular test designed for the detection of harmful intestinal bacteria that cause acute gastroenteritis. The test comes as an extension to the BD MAX real-time PCR enteric bacterial panel.
FDA clears BD's intestinal bacteria test
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.